LifePoint, Inc (LFPI) Fair Value & Analysis
Healthcare · US · Market cap $146K
LifePoint, Inc
LFPI · US
Fair value as of: Aug 19, 2026
From 1 valuation models · updated today
A solid business, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 19, 2026.
How to read this chart
60‑month range $0.0001 – $0.0070 · the $0.0003 price screens below the $0.0003 fair value. Dashed = 300-day average. As of Aug 19, 2026.
Analysis
LifePoint, Inc (LFPI) currently trades at $0.0003, while our model-based Fair Value estimate is $0.0003, implying the stock looks roughly 0.0% fairly valued today. The Quality Score stands at 50/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low), always confirm before acting.
Trailing-twelve-month revenue stands at $81.9K. The balance sheet holds a net cash position of $3.3M. Fundamentals as of Aug 19, 2026
The share trades near its 52-week high. For context, the median of 10 Healthcare peers we cover trades at -46% fair-value upside, at 0%, LFPI screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 1 models by family
Notify me when LFPI reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
Figures from reported company fundamentals · as of Aug 19, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 54 · Market factors (momentum, volatility) 50
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
LifePoint, Inc. develops, manufactures, and sells IMPACT Test System, a diagnostic testing and screening device. It serves workplaces, ambulances, pharmacies, law enforcements, and home health care markets. LifePoint, Inc. was formerly known as US Drug Testing, Inc. and changed its name to LifePoint, Inc. in February 1998.
Full company description
LifePoint, Inc. develops, manufactures, and sells IMPACT Test System, a diagnostic testing and screening device. It serves workplaces, ambulances, pharmacies, law enforcements, and home health care markets. LifePoint, Inc. was formerly known as US Drug Testing, Inc. and changed its name to LifePoint, Inc. in February 1998. The company was incorporated in 1992 and is based in Ontario, California.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2000 – FY2004 · reported fiscal years
LifePoint, Inc reported revenue of −$18.5K in FY2004 versus $1 in FY2000. Reported net income was −$15.2M in FY2004.
Watch LFPI: get an alert when its fair value changes →
Peer Group
Medical Instruments & Supplies · 204 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Instruments & Supplies median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate (as of Aug 19, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Intuitive Surgical, Inc ISRG | $401.27 | $150.04 | -63% |
| EssilorLuxottica Société anonyme 1EL | €164.40 | €68.55 | -58% |
| Medline Inc MDLN | $35.50 | $30.15 | -15% |
| Becton, Dickinson and Company BDX | $182.09 | $100.46 | -45% |
| Alcon Inc ALC | $73.58 | $39.78 | -46% |
| ResMed Inc RMD | $226.00 | $187.89 | -17% |
| West Pharmaceutical Services, Inc WST | $352.29 | $141.58 | -60% |
| Sartorius Stedim Biotech S.A DIM | €180.30 | €48.88 | -73% |
| Coloplast A/S COLOB | kr 429.70 | kr 382.22 | -11% |
| Gan & Lee Pharmaceuticals., a biopharmaceutical company, 603087 | ¥77.48 | ¥27.22 | -65% |
Compare LifePoint, Inc with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is LifePoint, Inc (LFPI) overvalued or undervalued?
What is the fair value of LFPI?
What is the quality score of LFPI?
What is the revenue of LifePoint, Inc (LFPI)?
What is the net profit margin of LFPI?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track LifePoint, Inc and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.